DIGNITANA, INC.
DALLAS, TX

Cancer patients undergoing chemotherapy have faced the almost inevitable prospect of losing their hair. While scalp cooling during chemotherapy has long been known as an effective method to help to prevent that hair loss, until recently patients in the U.S. did not have access to an FDA-cleared scalp cooling treatment. For over a decade, DigniCap® has successfully helped thousands of patients outside the United States. Now, with FDA clearance, infusion centers across the country will be able to offer this important treatment option directly to U.S. patients as part of their chemotherapy treatment. The silicone cooling cap will be fitted to your head by the infusion center staff 30 minutes before you start the chemotherapy treatment (pre-infusion cooling time). A neoprene outer cap will then be placed over the silicone cap to provide insulation and to help ensure a snug fit. The DigniCap® Scalp Cooling System offers you the chance to keep your hair during chemotherapy. However, chemotherapy can cause scalp irritation and cause your hair to become dry, brittle and more difficult to manage. The following recommendations will help insure you get the best results from your DigniCap® treatment: Avoid applying products that contain harsh chemicals to your hair such as the following: Parabens (such a methylparaben and propylparaben) that are commonly used as preservatives in hair products Cancer patients undergoing chemotherapy have faced the almost inevitable prospect of losing their hair. While scalp cooling during chemotherapy has long been known as an effective method to help to prevent that hair loss, until recently patients in the U.S. did not have access to an FDA-cleared scalp cooling treatment. For over a decade, DigniCap® has successfully helped thousands of patients outside the United States. Now, with FDA clearance, infusion centers across the country will be able to offer this important treatment option directly to U.S. patients as part of their chemotherapy treatment. Cancer patients undergoing chemotherapy have faced the almost inevitable prospect of losing their hair. While scalp cooling during chemotherapy has long been known as an effective method to help to prevent that hair loss, until recently patients in the U.S. did not have access to an FDA-cleared scalp cooling treatment. For over a decade, DigniCap® has successfully helped thousands of patients outside the United States. Now, with FDA clearance, infusion centers across the country will be able to offer this important treatment option directly to U.S. patients as part of their chemotherapy treatment. THIS SITE IS DIRECTED ONLY TO U.S. CONSUMERS FOR PRODUCTS AND SERVICES OF DIGNITANA, INC. This web site is not directed to consumers outside of the U.S.